Marinković Natalija, Pasalić Daria, Grsković Branka, Ferencak Goran, Honović Lorena, Rukavina Ana Stavljenić
Department of Chemistry and Biochemistry, School of Medicine, University of Zagreb, Zagreb, Croatia.
Coll Antropol. 2008 Sep;32(3):725-9.
Increased serum bilirubin levels in patients with Gilbert syndrome (GS) are caused by reduction of hepatic activity of bilirubin glucuronosyltranferase to about 30% of normal. UGT1A1 genetic polymorphism with absent or very low bilirubin UDP-glucuronosyltransferase (B-UGT) activity is associated with Gilbert's syndrome (GS) and other hyperbilirubinemias. The genetic basis of GS is the insertion of two additional TA nucleotides (resulting in seven repeats of TA) in the TATAA box, present in proximal promoter of UGT1A1 gene. This study included 323 Croatian pre-scholars, including 164 boys and 159 girls. Statistical analysis showed significant difference for total bilirubin concentration between different genotypes (p < 0.001). Also, statistically significant difference for total bilirubin concentration was emphasized between genotypes 6/6 and 7/7 (p < 0.001) as well as 6/7 and 7/7 (p < 0.001). Higher total plasma bilirubin concentrations are significantly correlated with 7/7 genotype which is present in 9.8% of population studied.
吉尔伯特综合征(GS)患者血清胆红素水平升高是由于胆红素葡萄糖醛酸转移酶的肝脏活性降低至正常水平的约30%所致。缺乏或极低胆红素UDP - 葡萄糖醛酸转移酶(B - UGT)活性的UGT1A1基因多态性与吉尔伯特综合征(GS)及其他高胆红素血症相关。GS的遗传基础是UGT1A1基因近端启动子中TATAA盒插入了两个额外的TA核苷酸(导致TA重复七次)。本研究纳入了323名克罗地亚学龄前儿童,其中包括164名男孩和159名女孩。统计分析显示不同基因型之间总胆红素浓度存在显著差异(p < 0.001)。此外,6/6和7/7基因型之间(p < 0.001)以及6/7和7/7基因型之间(p < 0.001)总胆红素浓度的统计学显著差异也得到强调。较高的总血浆胆红素浓度与7/7基因型显著相关,该基因型在所研究人群中占9.8%。